Skip to content

Immediate Versus Delayed Induction in Term-PROM Using or Not Antibiotic Prophylaxis

The Role of Antibiotic Prophylaxis in Immediate Versus Delayed Induction in Term-PROM - a Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02985086
Enrollment
568
Registered
2016-12-07
Start date
2013-07-31
Completion date
2018-07-31
Last updated
2016-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maternal Infection During Pregnancy (Diagnosis), Neonatal Infection

Keywords

term premature rupture of membranes, antibiotic prophylaxis, chorioamnionitis, endometritis, neonatal infection

Brief summary

The primary aim of this study is to determine if antibiotics combined with immediate induction can significantly reduce the rate of maternal and neonatal infection compared with immediate induction alone in women presenting with PROM later than the 37+0 weeks of gestation. The secondary aim is to compare the rates of infection between immediate and delayed induction in women submitted to antibiotic prophylaxis.

Detailed description

In a randomized controlled non-blind trial, low-risk women with singleton term pregnancies and a negative Group B Streptococcus culture presenting with PROM are randomly assigned to group A (immediate induction with antibiotic prophylaxis), group B (immediate induction without antibiotic prophylaxis) or group C (delayed induction with antibiotic prophylaxis).

Interventions

DRUGoxytocin/misoprostol

Sponsors

Hospital de Santa Maria, Portugal
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* term (≥ 37+0 weeks) singleton pregnancy, a vertex presentation, ruptured membranes for less than 12 hours and a negative Group B Streptococcus (GBS) culture performed between 35 and 37 weeks.

Exclusion criteria

* active labor, absence of GBS culture or indication for GBS antibiotic prophylaxis, contraindication to expectant management or to vaginal delivery

Design outcomes

Primary

MeasureTime frame
Maternal and neonatal infection rateintrapartum and immediate postpartum

Countries

Portugal

Contacts

Primary ContactFilipa FV Passos, MD
filipafariavazpassos@gmail.com00351966634530
Backup ContactRita Silva, MD
r.i.t.a.i.m.s.i.l.v.a@gmail.com00351963915366

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026